Core Viewpoint - The company has received approval from the National Medical Products Administration for its product, Crizotinib capsules, which has been in the Chinese market since 2013 and included in medical insurance since 2018, demonstrating over ten years of clinical application experience [1] Group 1 - Crizotinib capsules are primarily used for treating locally advanced or metastatic non-small cell lung cancer (NSCLC) patients who are positive for anaplastic lymphoma kinase (ALK) and for those with advanced NSCLC who are positive for ROS1 [1]

Core Viewpoint - Huason Pharmaceutical (002907.SZ) has received the drug registration certificate from the National Medical Products Administration for Crizotinib capsules, which have been on the Chinese market since 2013 and included in medical insurance since 2018, demonstrating over ten years of clinical application experience [1] Group 1 - Crizotinib capsules are primarily used for treating patients with ALK-positive locally advanced or metastatic non-small cell lung cancer (NSCLC) and ROS1-positive advanced NSCLC [1] - As a first-line treatment option, Crizotinib capsules provide over seven years of overall survival benefits for patients with advanced ALK/ROS1-positive NSCLC [1] - Crizotinib is the world's first targeted drug for ALK and the first-generation ALK tyrosine kinase inhibitor (ALK-TKI), targeting ALK and ROS1 to inhibit tumor cell proliferation and survival through a multi-target mechanism [1]

Core Viewpoint - The company has received approval from the National Medical Products Administration for the drug registration certificate of Crizotinib capsules, indicating a significant advancement in its product portfolio [1] Group 1: Product Approval - The product Crizotinib capsules are primarily used for the treatment of ALK-positive locally advanced or metastatic non-small cell lung cancer (NSCLC) patients [1] - Crizotinib is also indicated for ROS1-positive advanced non-small cell lung cancer (NSCLC) patients [1]

Core Viewpoint - Huason Pharmaceutical (002907.SZ) announced a share reduction plan by its controlling shareholder and an associated fund, which will not affect the company's control or governance structure [1][3]. Share Reduction Plan - Shareholder You Hongtao plans to reduce up to 6,649,826 shares through block trading, accounting for 1.59% of the total share capital, within three months starting from November 6, 2025 [1]. - Shanghai Tiancheng Investment Management Co., Ltd. plans to reduce up to 5,878,000 shares, comprising 1.41% of the total share capital, through both centralized bidding and block trading [1][2]. Financial Implications - The total planned reduction by You Hongtao and Tiancheng Tianli No.1 Fund amounts to 12,527,826 shares, or 3% of the total share capital, with an estimated cash-out of approximately 204.96 million yuan based on the last closing price of 16.36 yuan per share [2][3]. Shareholding Structure - As of the announcement date, You Hongtao holds 72,422,000 shares, while Tiancheng Tianli No.1 Fund holds 5,878,000 shares [3]. - The controlling shareholders, including You Hongtao, have a combined holding of 68% as of June 30, 2025, and the reduction will not lead to a change in control [3]. Previous Share Reductions - From June 6 to July 29, 2025, the controlling shareholder Chengdu Dijiang reduced 12,527,826 shares, representing 3% of the total share capital, with a reduction amounting to approximately 194 million to 216 million yuan [4].

Group 1 - Huayi Technology's shareholder plans to reduce holdings by up to 3% of the company's shares, totaling no more than 2.5433 million shares, from November 5, 2025, to February 4, 2026 [1] - Huayi Technology specializes in intelligent testing equipment for automotive powertrains, testing services for new energy vehicles, and intelligent driving-related businesses [1] - China Overseas Land & Investment reported a contract sales amount of 1.08 billion yuan in September, a year-on-year decrease of 59% [1] Group 2 - Degute announced it does not participate in nuclear energy or nuclear pollution control equipment manufacturing, focusing instead on energy-saving and environmental protection equipment [2] - Degute's main business targets chemical, energy, metallurgy, and solid waste treatment sectors [2][3] Group 3 - Zhongke Sanhuan expects a net profit of 80 million to 100 million yuan for the first three quarters of 2025, compared to a loss of 42.053 million yuan in the same period last year [4] - The company specializes in rare earth permanent magnet materials and new magnetic materials [4] Group 4 - Jieshun Technology anticipates a net profit of 68 million to 80 million yuan for the first three quarters of 2025, representing a year-on-year increase of 58.11% to 86.01% [5] - The company focuses on intelligent parking management systems and related services [5] Group 5 - Shengtun Mining plans to acquire Canadian Loncor's gold mine assets for approximately 1.35 billion yuan (190 million USD) [6] - The acquisition targets the Adumbi gold mine project in the Democratic Republic of the Congo, which has significant resource potential [6][7] Group 6 - Xizi Clean Energy reported new orders of 1.27 billion yuan in the third quarter, with total new orders of 4.054 billion yuan for 2025 [7] - The company specializes in waste heat boilers and clean energy generation equipment [7] Group 7 - Xiangsha Precision plans to invest 49% in a new investment fund focused on humanoid robots and industrial robots, with a total subscription amount of 49 million yuan [8] - The fund aims to invest in key components for humanoid robots and industrial service robots [8] Group 8 - Huangting International announced the termination of major asset sales and debt restructuring due to failure to reach consensus on core terms [10] - The company faces potential financial risks as its main assets have been judicially determined to be used for debt repayment [10] Group 9 - Jinlang Technology reported a net profit growth of 29.39% year-on-year for the first three quarters of 2025, with a total revenue of 5.663 billion yuan [12][13] - The company specializes in the research, production, and sales of string inverters for solar power generation [12] Group 10 - Guoen Co. signed a cooperation agreement for a photovoltaic production increase and seawater lithium extraction project, with a total funding of 26.7 million HKD from both parties [14] - The project focuses on enhancing photovoltaic cooling efficiency and developing lithium extraction systems [14] Group 11 - Aerospace Intelligent Manufacturing expects a net profit of 600 million to 664 million yuan for the first three quarters of 2025, representing a year-on-year increase of 12% to 24% [15] - The company operates in the automotive parts, oil and gas equipment, and high-performance functional materials sectors [15] Group 12 - Fuxin Technology's shareholder plans to transfer 3% of the company's shares, totaling 2.6472 million shares, due to personal funding needs [16] - The company specializes in the research, production, and sales of conductive silver paste for photovoltaic cells [16] Group 13 - Dike Co. plans to acquire 62.5% of Jiangsu Jingkai Semiconductor Technology Co. for 300 million yuan, focusing on storage chip packaging and testing services [17] - The acquisition will make Dike Co. the controlling shareholder of Jiangsu Jingkai [17] Group 14 - Phoenix Shipping plans to purchase dry bulk carriers for up to 60 million USD to expand its capacity and optimize fleet structure [18] - The funding will come from self-owned and raised funds [18] Group 15 - Ru Yi Group is under investigation by the China Securities Regulatory Commission for suspected information disclosure violations [21] - The company continues normal production and operational activities during the investigation [21] Group 16 - Kuntai Co. signed a cooperation letter of intent with French company Trèves to establish a carpet production line in Morocco [23] - The agreement ensures a long-term supply of automotive carpets to Trèves for five years [23] Group 17 - Huason Pharmaceutical's shareholders plan to reduce their holdings by up to 3% of the company's shares, totaling 12.5278 million shares [25] - The reduction is due to personal and fund funding needs [25] Group 18 - Zhongshe Co. plans to acquire 51% of Wuxi Jiaojian New Materials for 68.85 million yuan, focusing on asphalt and stabilized mixture production [27] - The acquisition will enhance Zhongshe's capabilities in the transportation and construction sectors [27] Group 19 - Tai Jia Co. plans to transfer its 2.5% stake in a venture capital fund for 14.3827 million yuan [28] - The transaction will result in Tai Jia no longer holding any shares in the fund [28] Group 20 - Weilan Lithium Core plans to invest 20 million USD in the Green Beauty Indonesia project to enhance its market competitiveness [30] - The investment will result in a 5.95% stake in the target company, which produces high-nickel ternary precursors [30] Group 21 - Guosheng Technology's subsidiary plans to invest 230 million yuan in Tieling Global for a solid-state battery project [32] - The investment will result in a 51.11% stake in Tieling Global, integrating the solid-state battery supply chain [32]

Core Insights - The article highlights significant corporate announcements and developments in various companies, including project investments, contract wins, share buybacks, and performance forecasts. Company Announcements - **DeguTech**: Not involved in the core equipment manufacturing for nuclear energy or nuclear pollution management [1] - **Kuntai Co.**: Plans to establish an automotive carpet production line in Morocco and supply to Trèves [1] - **Shan Jian Co.**: Awarded the EPC general contracting project for the 150MW Fenghuangling Wind Power Project in Guangxi [1] - **Dike Co.**: Plans to acquire 62.5% equity in Jiangsu Jingkai to strengthen its core competitiveness in storage business [1] - **Trina Solar**: Has repurchased 0.9964% of its own shares [1] - **Xian Da Co.**: Expects a net profit increase of 2807.87% to 3211.74% year-on-year for the first three quarters [1] - **Huason Pharmaceutical**: Controlling shareholder's concerted action party plans to reduce holdings by no more than 3% [2] - **Rima Precision**: Secured a project for automotive air suspension system products [2] - **Guangda Special Materials**: Chairman and General Manager Xu Weiming has been subjected to retention measures [2] Performance Forecasts - **Batian Co.**: Anticipates a net profit growth of 230.79% to 260.15% year-on-year for the first three quarters [1] - **Shenghe Resources**: Expects a year-on-year net profit increase of 696.82% to 782.96% for the first three quarters [1]

Summary of Key Points Core Viewpoint - Several companies are experiencing significant shareholder reductions, with multiple stakeholders planning to decrease their holdings by various percentages, indicating potential shifts in investor confidence and market dynamics [1]. Shareholder Reductions - Watson Pharmaceutical's controlling shareholder plans to reduce holdings by up to 3% [1] - Tianli Lithium Energy's New Materials Fund intends to reduce holdings by up to 3% [1] - Guangkang Biochemical's shareholder Ruihong Kaiyin No.1 plans to reduce holdings by up to 2.6757% [1] - Huayi Technology's shareholder Huang Daqing aims to reduce holdings by no more than 3% [1] - Magu Technology's shareholder Xu Longxiang plans to reduce holdings by up to 0.86% [1] - Saiwu Technology's shareholders Suzhou Suyu and Suzhou Saiying plan to collectively reduce holdings by 1.32% [1] - New Xunda's Minmetals International Trust has cumulatively reduced holdings by 1% [1] - Yandong Micro's Jingguorui has cumulatively reduced 1% of company shares [1] - Aohua Endoscopy's shareholders Junlian Xinkang and Gao Shen have cumulatively reduced 1.92% of shares [1] - Zhejiang Natural's Tiantai Ruiju Equity Investment Center has completed a 1% reduction in company shares [1] - Chunzong Technology's He Shida has cumulatively reduced 2 million shares [1] - Chiao Sensor's Li Hongqing has reduced 16 million shares through block trading [1] - Chuangye Huikang's Philips has cumulatively reduced 1.0195% of shares [1] Other Notable Events - Ruyi Group is under investigation by the China Securities Regulatory Commission for suspected information disclosure violations [1] - Huangting International has terminated plans for significant asset sales and debt restructuring [1]

华森制药（002907）(002907.SZ)发布公告，公司于近日收到控股股东一致行动人游洪涛先生、上海添 橙投资管理有限公司-添橙添利一号私募证券投资基金(简称"添橙添利一号基金")发来的《关于计划减持 公司股份的告知函》，本次减持计划合计减持不超过1252.78万股，不超过公司总股本的3%。 ...

智通财经APP讯，华森制药(002907.SZ)发布公告，公司于近日收到控股股东一致行动人游洪涛先生、上 海添橙投资管理有限公司-添橙添利一号私募证券投资基金(简称"添橙添利一号基金")发来的《关于计划 减持公司股份的告知函》，本次减持计划合计减持不超过1252.78万股，不超过公司总股本的3%。 ...

游洪涛先生与添橙添利一号基金为公司控股股东一致行动人，本次拟通过集中竞价方式减持公司股份不 超过4,175,900股，不超过公司总股本的1.00%；拟通过大宗交易方式减持公司股份8,351,926股，不超过 公司总股本的2.00%。本次减持计划合计减持不超过12,527,826股，不超过公司总股本的3%。 格隆汇10月14日丨华森制药(002907.SZ)公布，近日收到控股股东一致行动人游洪涛先生、上海添橙投 资管理有限公司－添橙添利一号私募证券投资基金（简称"添橙添利一号基金"）发来的《关于计划减持 公司股份的告知函》。持有公司72,422,000股股份的游洪涛先生计划自本公告披露之日起15个交易日后 的3个月内（即2025年11月6日至2026年2月5日）通过大宗交易方式减持公司股份合计不超过6,649,826 股，占公司总股本的1.59%。持有公司5,878,000股股份的添橙添利一号基金计划自本公告披露之日起15 个交易日后的3个月内（即2025年11月6日至2026年2月5日）通过集中竞价方式减持公司股份不超过 4,175,900股，占公司总股本的1.00%；通过大宗交易方式减持公司股份不超过1,7 ...